News

Portfolio will address industry’s demand for additional services that revolve around personalized patient treatments.

The treatments span various therapeutic areas, from antibiotic to oncology.

New capability will support manufacturing of commercial-stage therapies to help combat cancers and genetic diseases.

March stats show a 7.7% decline in demand compared to March 2022, but an improvement over the previous month.

A ‘next generation’ CRM platform will gradually leave the Salesforce.com platform behind.

Company delivers additional supply chain logistics and distribution experience to specialty pharmaceutical market.

New offering designed to combine proactive monitoring and personalized engagement.

The latest people news happenings over the past month.

“Deep learning” IT tools were used to calculate sales volumes and drug class.

From logistics lessons learned, how pharma can navigate new opportunities surfacing in ocean shipping.

Expert panel identifies five key areas where patient-centric strategies can benefit supply chains the most—and lead to better patient outcomes.

Multi-enterprise information tower to facilitate exchange of interoperable commerce, inventory, logistics, and other supply chain data.

Roundtable drills down on ways the two sectors can come together to reduce carbon emissions.

Real-time location monitoring solution allows increased visibility into the precise location of shipments in transit globally.

Panel discusses the importance of developing strong relationships in order to maximize partner and supplier visibility.

The platform agnostic CGT hub hopes to streamline the path-to-care process, by providing physicians and patient services teams with visibility across the therapy development and delivery process.

CDMO’s fill-finish line offers batch capacity of over 200,000 syringes.

In this latest Harvard Business School Healthcare Alumni Association Q&A, Dr. Peter Cappelli, Professor of Management at The Wharton School and Director of Wharton’s Center for Human Resources, explains how biopharma C-suites can lead their teams through 2023’s turbulent times.

Purchase solidifies group’s goal of expanding patient access to rare disease treatments.

Company will also financially commit $15 million for those pursuing pharma manufacturing careers.

Joint initiative integrates submitted claims with parties’ platforms in effort to avoid duplicate data.

Company acquires Makara Health, who will work alongside Precision’s branded medical and scientific agency.

Merger with pharmacovigilance service provider helps company expands its end-to-end solutions in the region.

The collaboration—the parties say—can help improve supply chain operations.

Agency hopes to attract more seasoned expertise in manufacturing; also looking to add field inspectors.

Demands for services in this sector have increased since last year’s Q1 Scientific acquisition, CDMO says.

Bourgoin hub broadens customer needs to also address commercial manufacturing.

Network aims to improve end-to-end supply chain visibility for the life sciences industry.

Rise in value attributed to the ongoing decentralization of pharmacies.

Deal is expected to boost company’s market access capabilities.